Scabies is a generally benign but highly contagious skin parasitic infection that can affect people of all ages and from all social backgrounds. Following various indications of a resurgence of the infection, we have compiled the results of seven studies conducted by the InVS/Cire between 2008 and 2010. Five studies conducted with local partners show an increase in reports of scabies outbreaks in group settings (schools, medical-social facilities, etc.). They also highlight delays in diagnosis and treatment (both individual and environmental), sometimes associated with financial difficulties or difficulties understanding prescriptions. Two studies show an increase in sales of scabicides at the regional and national levels. The national study shows increases of 11% and 24%, respectively, in sales of benzyl benzoate and ivermectin between 2005 and 2009. It estimates the incidence at between 330 and 350 cases of scabies per 105 inhabitants per year. In the absence of specific surveillance for scabies, these data should be interpreted with caution; however, the overall results indicate an increase in the incidence of scabies in France. Increased public and clinician awareness regarding early diagnosis, along with better coordination among local and regional stakeholders (ARS-DT, Cire, CClin where applicable), would help improve management and limit the spread of the infection, particularly in complex situations. (R.A.)